133 related articles for article (PubMed ID: 21820215)
1. [Radioguided cervical lymphadenectomy in one case of recurrence of differentiated thyroid microcarcinoma].
Frontado-Morales L; Martinez-Sanchis B; Sanchez-Vaño R; Caballero-Calabuig E; Abreu-Sanchez P; Reyes-Ojeda MD
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):106-7. PubMed ID: 21820215
[No Abstract] [Full Text] [Related]
2. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
3. Follow-up of differentiated thyroid cancer.
Pacini F
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
[TBL] [Abstract][Full Text] [Related]
4. Axillary lymph node metastasis in recurrence of papillary thyroid carcinoma: a case report.
Ers V; Galant C; Malaise J; Rahier J; Daumerie C
Wien Klin Wochenschr; 2006 Mar; 118(3-4):124-7. PubMed ID: 16703258
[TBL] [Abstract][Full Text] [Related]
5. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report].
Ortega F; Maldonado A; Marañes P; Montz R; Pérez-Castejón MJ; Melgarejo M; Ruiz JA; Carreras JL
Rev Esp Med Nucl; 1999; 18(1):50-4. PubMed ID: 10074219
[TBL] [Abstract][Full Text] [Related]
6. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer.
Paloyan E; Walker RP; Lawrence AM
Surg Oncol Clin N Am; 1998 Oct; 7(4):665-80. PubMed ID: 9735128
[TBL] [Abstract][Full Text] [Related]
8. Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate.
Bruno R; Giannasio P; Chiarella R; Capula C; Russo D; Filetti S; Costante G
Thyroid; 2009 May; 19(5):531-3. PubMed ID: 19416000
[TBL] [Abstract][Full Text] [Related]
9. [Papillary thyroid microcarcinoma presenting as cervical lymph node metastasis. Interest of tetrofosmin scintigraphy and lymph node thyroglobulin measurement].
Ajmi S; Hassine H; Sfar R; Grouz Z; Guezguez M; Adelkefi M; Essabbah H
Rev Laryngol Otol Rhinol (Bord); 2006; 127(3):179-82. PubMed ID: 17007193
[TBL] [Abstract][Full Text] [Related]
10. Role of nuclear medicine in staging and management in a case of Merkel cell carcinoma.
Ochoa-Figueroa MA; Uña-Gorospe J; Allende-Riera A; Muñoz-Iglesias J; Cárdenas-Negro C; González-Delgado B
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):354-6. PubMed ID: 23169391
[No Abstract] [Full Text] [Related]
11. [Use of 18F FDG-PET in patients with suspicion of recurrent differentiated thyroid cancer by elevated antithyroglobulin antibodies levels and negative ¹³¹I scan].
Sanz Viedma S; Borrego Dorado I; Rodríguez Rodríguez JR; Navarro González E; Vázquez Albertino R; Fernández López R; Agudo Martínez A
Rev Esp Med Nucl; 2011; 30(2):77-82. PubMed ID: 21334773
[TBL] [Abstract][Full Text] [Related]
12. Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels.
Pachón-Garrudo VM; Cuenca-Cuenca JI; Ruiz-Franco-Baux J; Borrego-Dorado I; Tirado-Hospital JL; Navarro-González E; Vázquez-Albertino R
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):315-21. PubMed ID: 23084014
[TBL] [Abstract][Full Text] [Related]
13. [Long-standing differentiated thyroid carcinoma].
Cabrejas Gómez Mdel C; Aguillo Gutiérrez E; Altemir Trallero J; Ocón Bretón J; Lázaro Sierra J
Endocrinol Nutr; 2012 Jan; 59(1):78-81. PubMed ID: 21835705
[No Abstract] [Full Text] [Related]
14. Gamma probe-guided resection of a lymph node metastasis with I-123 in papillary thyroid carcinoma.
Gallowitsch HJ; Fellinger J; Mikosch P; Kresnik E; Lind P
Clin Nucl Med; 1997 Sep; 22(9):591-2. PubMed ID: 9298290
[TBL] [Abstract][Full Text] [Related]
15. Radioiodine SPET/CT guided needle aspiration as a useful technique for recurrence surveillance in a thyroidectomized differentiated thyroid cancer patient with negative US and serum Tg and positive Tg of the lymph node aspirate.
Ahn BC
Hell J Nucl Med; 2013; 16(2):142-3. PubMed ID: 23865086
[No Abstract] [Full Text] [Related]
16. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract][Full Text] [Related]
17. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
18. Extensive lymph node metastases found by (18)F-FDG-PET/CT in a patient with diffuse sclerosing variant of papillary thyroid carcinoma.
Xu YH; Song HJ; Qiu ZL; Luo QY
Hell J Nucl Med; 2011; 14(2):188-9. PubMed ID: 21761030
[No Abstract] [Full Text] [Related]
19. Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative I-131 whole body scan.
Wu HS; Huang WS; Liu YC; Yen RF; Shen YY; Kao CH
Anticancer Res; 2003; 23(5b):4235-8. PubMed ID: 14666632
[TBL] [Abstract][Full Text] [Related]
20. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
